Population dynamics of some relevant intestinal microbial groups in human fecal batch cultures with added fermentable xylooligosaccharides obtained from rice husks

BioResources

Volumn 8, Issue 2, 2013, Pages 2429-2441

  Valdés, Lorena ^a   Gullón, Patricia ^b   Salazar, Nuria ^a,d   Rios Covián, David ^a   González Muñoz, Maria Jesús ^c   Parajó, Juan Carlos ^c   Ruas Madiedo, Patricia ^a   Gueimonde, Miguel ^a   de los Reyes Gavilán, Clara G ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^c UNIVERSITY OF VIGO   (Spain)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Bacteroides; Bifidobacterium species; Blautia coccoides Eubacterium rectale; Faecalibacterium prausnitzii; Fecal batch cultures; Lactobacillus; Rice husks; Xylooligosaccharides

Indexed keywords

BACTERIA; BATCH CELL CULTURE; FOOD PRODUCTS; PRODUCT DESIGN;

BACTEROIDES; BATCH CULTURE; BIFIDOBACTERIUM; BLAUTIA COCCOIDES-EUBACTERIUM RECTALE; FAECALIBACTERIUM PRAUSNITZII; LACTOBACILLUS; RICE HUSK; XYLOOLIGOSACCHARIDES;

POLYMERASE CHAIN REACTION;

EID: 84877962360     PISSN: None     EISSN: 19302126     Source Type: Journal    
DOI: 10.15376/biores.8.2.2429-2441     Document Type: Article

References (34)

1. Arboleya, S., Binetti, A. Salazar, N, Fernández, N., Solís, G., Hernández-Barranco, A., Margolles, A., de los Reyes-Gavilán, C. G., and Gueimonde, M. (2012). "Establishment and development of intestinal microbiota in preterm neonates," FEMS Microbiol. Ecol. 79(3), 763-772.
2. Barcenilla, A., Pryde, S. E., Martin, J. C., Duncan, S. H., Stewart, C. S., and Flint, H. J. (2000). "Phylogenetic relationships of dominant butyrate producing bacteria from the human gut," Appl. Environ. Microbiol. 66(4), 1654-1661.
3. Benus, R. F., van der Werf, T. S., Welling, G. W., Judd, P. A., Taylor, M. A., Harmsen, H. J., and Whelan, K. (2010). "Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects," Br. J. Nutr. 104(5), 693-700.
4. Broekaert, W. F., Courtin, C. M., Verbeke, K., van de Wiele, T., Verstraete, W., and Delcour, J. A. (2011). "Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides," Crit. Rev. Food Sci. Nutr. 51(2), 178-194.
5. Canani, R. B., Costanzo, M. D., Leone, L., Pedata, M., Meli, R., and Calignano, A. (2011). "Potential beneficial effects of butyrate in intestinal and extraintestinal diseases," World J. Gastroenterol. 17(12), 1519-1528.
6. Candela, M., Rampelli, S., Turroni, S., Severgnini, M., Consolandi, C., De Bellis, G., Masetti, R., Ricci, G., Pession, A., and Brigidi, P. (2012). "Unbalance of intestinal microbiota in atopic children," BMC Microbiol. 12, Article no. 95.
7. Davis, L. M., Martínez, I., Walter, J., and Hutkins, R. (2010). "A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults," Int. J. Food Microbiol. 144(2), 285-292.
8. De Palma, G., Nadal, I., Medina, M., Donat, E., Ribes-Koninckx, C., Calabuig, M., and Sanz, Y. (2010). "Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children," BMC Microbiol. 10, 63.
9. FAO/WHO (2007). "FAO technical meeting on prebiotics," WHO, Geneva, Switzerland. http.//www.fao.org/ag/agn/agns/files/Prebiotics_Tech_Meeting_Report.pdf.
10. Faust, K., Sathirapongsasuti, J. F., Izard, J., Segata, N., Gevers, D., Raes, J., and Huttenhower, C. (2012). "Microbial co-occurrence relationships in the human microbiome," PLoS Comput. Biol. 8(7), e1002606.
11. Gerritsen, J., Smidt, H., Rijkers, G. T., and de Vos, W. M. (2011). "Intestinal microbiota in human health and disease: The impact of probiotics," Genes Nutr. 6(3), 209-240.
12. Gibson, G., and Roberfroid, M. B. (1995). "Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics," J. Nutr. 125(6), 1401-1412.
13. Gueimonde, M., Debor, L., Tölkkö, S., Jokisalo, E., and Salminen, S. (2007). "Quantitative assessment of faecal bifidobacterial populations by real-time PCR using lanthanide probes," J. Appl. Microbiol. 102(4), 1116-1122.
14. Guilloteau, P., Martin, L., Eeckhaut, V., Ducatelle, R., Zabielski, R., and Van Immerseel, F. (2010). "From the gut to the peripheral tissues: The multiple effects of butyrate," Nutr. Res. Rev. 23(2), 366-384.
15. Gullón, P., Gullón, B., Moure, A., Alonso, J. L., Domínguez, H., and Parajó, J. C. (2009). "Prebiotic potential of xylo-oligosaccharides," Prebiotics and Probiotics Science and Technology, D. Charalampopoulos and R. A. Rastall (eds.), Springer, New York, USA.
16. Gullón, P., Salazar, N., González Muñoz, M. J., Gueimonde, M., Ruas-Madiedo, P., de los Reyes-Gavilán, C. G., and Parajó, J. C. (2011). "Assessment of the fermentability of xylooligosaccharides from rice husks," BioResources 6(3), 3096-3114.
17. Joossens, M., Huys, G., Van Steen, K., Cnockaert, M., Vermeire, S., Rutgeerts, P., Verbeke, K., Vandamme, P., and De Preter, V. (2011). "High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake," FEMS Microbiol. Ecol. 75(2), 343-349.
18. Jin, J. S., Touyama, M., Hisada, T., and Benno, Y. (2012). "Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species," Microbiol. Immunol. 56(11), 729-739.
19. Kolida, S., Meyer, D., and Gibson, G. R. (2007). "A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans," Eur. J. Clin. Nutr. 61(10), 1189-1195.
20. Li, Q., Wang, C., Tang, C., Li, N., and Li, J. (2012). "Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease," PLoS One 7(4), e34939.
21. Macfarlane, G. T., and Gibson, G. R. (1997). "Carbohydrate fermentation, energy transduction and gas metabolism in the human large intestine," Gastrointestinal Microbiology, R. I. Mackie and B. A. White (eds.), Chapman and Hall, London, England, 269-318.
22. Mäkeläinen, H., Forssten, S., Saarinen, M., Stowell, J., Rautonen, N., and Ouwehand, A. C. (2010). "Xylo-oligosaccharides enhance the growth of bifidobacteria and Bifidobacterium lactis in a simulated colon model," Benef. Microbes 1(1), 81-91.
23. Matsuki, T., Watanabe, K., Fujimoto, J., Kado, Y., Takada, T., Matsumoto, K., and Tanaka, R. (2004). "Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria," Appl. Environ. Microbiol. 70(1), 167-173.
24. Moura, P., Cabanas, S., Lourenco, P., Girio, F., Loureiro-Dias, M. C., and Esteves, M. P. (2008). "In vitro fermentation of selected xylo-oligosaccharides by piglet intestinal microbiota," LWT-Food Sci. Technol. 41(10), 1952-1961.
25. Muralikrishna, G., Schwarz, S., Dobleit, G., Fuhrmann, H., and Krueger, M. (2011). "Fermentation of feruloyl and non-feruloyl xylooligosaccharides by mixed fecal cultures of human and cow: A comparative study in vitro," Eur. Food Res. Technol. 232, 601-611.
26. Ohbuchi, T., Takahashi, T., Azumi, N., and Sakaino, M. (2009). "Structural analysis of neutral and acidic xylooligosaccharides from hardwook kraft pulp, and their utilization by intestinal bacteria in vitro," Biosci. Biotechnol. Biochem. 73(9), 2070-2076.
27. Pastell, H., Westermann, P., Meyer, A. S., Tuomainen, P., and Tenkanen, M. (2009). "In vitro fermentation of arabinoxlan-derived carbohydrates by bifidobacteria and mixed fecal microbiota," J. Agric. Food Chem. 57(18), 8598-8606.
28. Petersen, A., Bergström, A., Andersen, J. B., Hansen, M., Lahtinen, S. J., Wilcks, A., and Licht, T. R. (2010). "Analysis of the intestinal microbiota of oligosaccharide fed mice exhibiting reduced resistance to Salmonella infection," Benef. Microbes 1(3), 271-281.
29. Ramirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A., Holtrop, G., and Louis, P. (2009). "Effect of inulin on the human gut microbiota: Stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii," Br. J. Nutr. 101(4), 541-550.
30. Roberfroid, M., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R., Rowland, I., Wolvers, D., Watzl, B., Szajewska, H., Stahl, B., Guarner, F., Respondek, F., Whelan, K., Coxam, V., Davicco, M.-J., Léotoing, L., Wittrant, Y., Delzenne, N. M., Cani, P. D., Neyrinck, A. M., and Meheust, A. (2010). "Prebiotic effects: Metabolic and health benefits," Br. J. Nutr. 104(S2), S1-S63.
31. Saarinen, M. T., Lahtinen, S. J., Sorensen, J. F., Tiihonen, K., Ouwehand, A. C., Rautonen, N., and Morgan, A. (2012). "Treatment of bran containing bread by baking enzymes: Effect on the growth of probiotic bacteria on soluble dietary fiber extract in vitro," Biosci. Biotechnol. Biochem. 76(6), 1135-1139.
32. Salazar, N., Gueimonde, M., Hernández-Barranco, A. M., Ruas-Madiedo, P., and de los Reyes-Gavilán, C. G. (2008). "Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria," Appl. Environ. Microbiol. 74(15), 4737-4745.
33. Salazar, N., Ruas-Madiedo, P., Kolida, S., Collins, M., Rastall, R., Gibson, G., and de los Reyes-Gavilán, C. G. (2009). "Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures," Int. J. Food Microbiol. 135(3), 260-267.
34. Santos, A., San Mauro, M., and Díaz, D. M. (2006). "Prebiotics and their long-term influence on the microbial populations of the mouse bowel," Food Microbiol. 23(5), 498-503.